FDA Lays Out Must Haves for Topical OTCs

Drug Industry Daily
The FDA is willing to hold private meetings with sponsors of over-the-counter creams, gels and other topical medicines in order to protect trade secrets—but sponsors should understand that the meetings will eventually see the light of day, the agency says.

To View This Article:


Subscribe To Drug Industry Daily